Health articles
What the evidence shows about GLP-1 weight-loss treatments (Wegovy, Mounjaro, Ozempic, Saxenda) and about perimenopause, menopause, HRT and hot flashes.

Hot Flashes and Night Sweats: Causes, How Long They Last and Treatment Options
Why menopausal hot flashes and night sweats happen, how long they usually last, and which treatments have good evidence, with and without hormones.

HRT Benefits and Risks: Is Hormone Therapy Safe? What the Numbers Show
Is HRT safe? The benefits and risks of menopausal hormone therapy in absolute numbers per 1,000 women, from NICE and the WHI trials.

Menopause Symptoms, Average Age and Diagnosis: What to Expect
Menopause is confirmed after 12 months without a period, usually around age 51. What the symptoms are, how it is diagnosed, how long it lasts and why early menopause needs attention.

Perimenopause Symptoms, Age and How Long It Lasts: A Clear Guide
Perimenopause can start in your late 30s or 40s and last several years. The first signs, irregular periods, when tests help, pregnancy risk and treatment options, explained with NICE and NHS guidance.

Types of HRT: Patch, Gel or Tablets, Progesterone and How Treatment Works
HRT is not one medicine but a set of choices: which estrogen, which route, which progestogen and which regimen. Here is how the options differ and what the first months of treatment usually look like.

The Wegovy pill after injections: what the OCTANE study shows
Patients who switched from injections to the Wegovy pill kept losing weight. What the study actually shows, and what it means for you.

The Minimum Effective GLP-1 Dose: Do You Need the Maximum Dose?
Not everyone needs the maximum GLP-1 dose. What trials show about lower doses and what the official prescribing information allows.

Mounjaro 5 mg vs 10 mg vs 15 mg: what the trials show
SURMOUNT-1 results for each Mounjaro dose: weight loss, side effects and what it means for you.

Lowering the dose after weight loss: what the SURMOUNT-MAINTAIN trial shows
The first large trial on lowering the dose after weight loss: what happens on the full dose, on 5 mg and after stopping treatment.

GLP-1 Microdosing (Ozempic, Mounjaro): What's Real and What's Marketing
GLP-1 microdosing is a trend with no studies behind it. What's real, what the risks are, and what safe alternative exists.

Ozempic overdose: why it isn't safe to calculate your own dose
Hand-measured doses have led to real overdoses. Why the errors happen, what the FDA reported and the signs that mean you should call your doctor.

Reducing your GLP-1 dose: how to talk to your doctor
Legitimate reasons for a lower dose, what to prepare before your appointment and the questions to ask your doctor.

GLP-1 and Addiction: Can They Reduce Cravings for Alcohol and Cigarettes?
Do GLP-1 medications reduce cravings for alcohol and cigarettes? What studies show (especially for alcohol), the mechanism, and the essential caveats.

The future of GLP-1: pills and the next generation of medicines
GLP-1 pills are now a reality: the Wegovy pill is approved in the EU, orforglipron in the US. What's approved, what's coming next and what it means for you.

Sleep Apnea and GLP-1 Medications: The Link With Weight
Sleep apnea is serious and closely tied to weight. How standard treatment (CPAP) and the new GLP-1/GIP medications complement each other.

GLP-1 and Fertility: The "Ozempic Babies" Phenomenon, Explained
Why unexpected pregnancies occur in women taking GLP-1 medications, the link with PCOS, and why these drugs are not taken during pregnancy.

GLP-1 and the Heart/Kidneys: Benefits Beyond Weight Loss
GLP-1 medications don't just help you lose weight: trials show benefits for the heart and kidneys. What the data say and who they're for.

Mounjaro vs Wegovy: differences, results and how to choose (2026 guide)
A complete Mounjaro vs Wegovy comparison: mechanism, trial results, dose escalation, side effects, cost and how to choose between them.

Wegovy and Mounjaro Side Effects: What to Know and How to Manage Them
An in-depth guide to Wegovy and Mounjaro side effects: the common (digestive) ones, the rare ones, how to reduce them, and when to contact your doctor.